Pacific Biosciences Of California Retained Earnings (Accumulated Deficit) 2010-2025 | PACB
Pacific Biosciences Of California retained earnings (accumulated deficit) from 2010 to 2025. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| Pacific Biosciences Of California Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $-2,149 |
| 2023 | $-1,839 |
| 2022 | $-1,532 |
| 2021 | $-1,218 |
| 2020 | $-1,037 |
| 2019 | $-1,066 |
| 2018 | $-982 |
| 2017 | $-880 |
| 2016 | $-788 |
| 2015 | $-713 |
| 2014 | $-681 |
| 2013 | $-615 |
| 2012 | $-536 |
| 2011 | $-442 |
| 2010 | $-332 |
| 2009 | $-192 |
| Pacific Biosciences Of California Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2025-03-31 | $-2,575 |
| 2024-12-31 | $-2,149 |
| 2024-09-30 | $-2,151 |
| 2024-06-30 | $-2,091 |
| 2024-03-31 | $-1,917 |
| 2023-12-31 | $-1,839 |
| 2023-09-30 | $-1,757 |
| 2023-06-30 | $-1,690 |
| 2023-03-31 | $-1,620 |
| 2022-12-31 | $-1,532 |
| 2022-09-30 | $-1,448 |
| 2022-06-30 | $-1,371 |
| 2022-03-31 | $-1,300 |
| 2021-12-31 | $-1,218 |
| 2021-09-30 | $-1,149 |
| 2021-06-30 | $-1,165 |
| 2021-03-31 | $-1,124 |
| 2020-12-31 | $-1,037 |
| 2020-09-30 | $-1,112 |
| 2020-06-30 | $-1,088 |
| 2020-03-31 | $-1,065 |
| 2019-12-31 | $-1,066 |
| 2019-09-30 | $-1,066 |
| 2019-06-30 | $-1,037 |
| 2019-03-31 | $-1,012 |
| 2018-12-31 | $-982 |
| 2018-09-30 | $-951 |
| 2018-06-30 | $-926 |
| 2018-03-31 | $-904 |
| 2017-12-31 | $-880 |
| 2017-09-30 | $-859 |
| 2017-06-30 | $-837 |
| 2017-03-31 | $-811 |
| 2016-12-31 | $-788 |
| 2016-09-30 | $-769 |
| 2016-06-30 | $-751 |
| 2016-03-31 | $-733 |
| 2015-12-31 | $-713 |
| 2015-09-30 | $-712 |
| 2015-06-30 | $-714 |
| 2015-03-31 | $-702 |
| 2014-12-31 | $-681 |
| 2014-09-30 | $-662 |
| 2014-06-30 | $-653 |
| 2014-03-31 | $-634 |
| 2013-12-31 | $-615 |
| 2013-09-30 | $-598 |
| 2013-06-30 | $-578 |
| 2013-03-31 | $-557 |
| 2012-12-31 | $-536 |
| 2012-09-30 | $-514 |
| 2012-06-30 | $-492 |
| 2012-03-31 | $-469 |
| 2011-12-31 | $-442 |
| 2011-09-30 | $-419 |
| 2011-06-30 | $-389 |
| 2011-03-31 | $-367 |
| 2010-12-31 | $-332 |
| 2010-09-30 | $-296 |
| 2010-06-30 | |
| 2010-03-31 | |
| 2009-12-31 | |
| 2009-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.315B | $0.154B |
| Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $197.793B | 86.63 |
| Thermo Fisher Scientific (TMO) | United States | $150.971B | 18.26 |
| Edwards Lifesciences (EW) | United States | $45.591B | 29.89 |
| IDEXX Laboratories (IDXX) | United States | $42.288B | 48.60 |
| Alcon (ALC) | Switzerland | $42.138B | 28.48 |
| DexCom (DXCM) | United States | $34.031B | 52.60 |
| IQVIA Holdings (IQV) | United States | $24.701B | 13.84 |
| Mettler-Toledo (MTD) | United States | $24.242B | 28.83 |
| STERIS (STE) | Ireland | $23.937B | 26.36 |
| Waters (WAT) | United States | $20.792B | 29.34 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.231B | 0.00 |
| Hologic (HOLX) | United States | $14.048B | 15.26 |
| Sysmex ADR (SSMXY) | Japan | $10.336B | 29.32 |
| Penumbra (PEN) | United States | $9.967B | 78.22 |
| Masimo (MASI) | United States | $8.883B | 32.77 |
| Globus Medical (GMED) | United States | $8.082B | 19.26 |
| Glaukos (GKOS) | United States | $5.399B | 0.00 |
| Teleflex (TFX) | United States | $5.366B | 8.86 |
| TransMedics (TMDX) | United States | $4.355B | 94.66 |
| Integer Holdings (ITGR) | United States | $4.182B | 21.91 |
| PROCEPT BioRobotics (PRCT) | United States | $3.319B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.405B | 14.32 |
| Veracyte (VCYT) | United States | $2.075B | 29.12 |
| Nihon Kohden (NHNKY) | Japan | $2.022B | 23.20 |
| Elekta AB (EKTAY) | Sweden | $1.956B | 17.59 |
| Alphatec Holdings (ATEC) | United States | $1.851B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.374B | 0.00 |
| Artivion (AORT) | United States | $1.215B | 113.80 |
| Pulse Biosciences (PLSE) | United States | $1.186B | 0.00 |
| OPKO Health (OPK) | United States | $1.094B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.013B | 5.39 |
| SiBone (SIBN) | United States | $0.805B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.779B | 0.00 |
| IRadimed (IRMD) | United States | $0.760B | 38.57 |
| RxSight (RXST) | United States | $0.642B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.576B | 8.96 |
| Delcath Systems (DCTH) | United States | $0.560B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.546B | 12.80 |
| AxoGen (AXGN) | United States | $0.517B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.496B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.445B | 0.00 |
| NeuroPace (NPCE) | United States | $0.444B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.432B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.397B | 10.56 |
| Treace Medical Concepts (TMCI) | United States | $0.365B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.354B | 0.00 |
| Neuronetics (STIM) | United States | $0.254B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.239B | 14.48 |
| 908 Devices (MASS) | United States | $0.237B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.208B | 0.00 |
| CVRx (CVRX) | United States | $0.176B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.175B | 0.00 |
| Inogen (INGN) | United States | $0.172B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.163B | 0.00 |
| Accuray (ARAY) | United States | $0.162B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.161B | 0.00 |
| LENSAR (LNSR) | United States | $0.160B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.136B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.110B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.099B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.087B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.079B | 48.30 |
| InspireMD (NSPR) | United States | $0.078B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.061B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| Positron (POSC) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.044B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.028B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.19 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |